LENZ Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- LENZ Therapeutics's estimated annual revenue is currently $2.8M per year.
- LENZ Therapeutics's estimated revenue per employee is $100,500
- LENZ Therapeutics's total funding is $50.4M.
Employee Data
- LENZ Therapeutics has 28 Employees.
- LENZ Therapeutics grew their employee count by 56% last year.
LENZ Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Head Commercial Operations | Reveal Email/Phone |
3 | VP Quality | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | VP Sales | Reveal Email/Phone |
6 | VP, Clinical Operations | Reveal Email/Phone |
7 | VP, CMC and Manufacturing | Reveal Email/Phone |
8 | Senior Director, Marketing & Alliance Management | Reveal Email/Phone |
9 | Director Supply Chain | Reveal Email/Phone |
10 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
LENZ Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is LENZ Therapeutics?
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.
keywords:N/A$50.4M
Total Funding
28
Number of Employees
$2.8M
Revenue (est)
56%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LENZ Therapeutics News
Orasis Pharmaceuticals; AbbVie Inc. Novartis AG; OSRX Pharmaceuticals; LENZ Therapeutics; Visus Therapeutics; Ocuphire Pharma Inc. Eyenovia,...
... a licensing deal with LENZ Therapeutics for its two presbyopia candidates. ... The industry-wide effort to push CAR-T therapies wildly...
LENZ is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Its lead programs, LNZ100...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.2M | 28 | 33% | $18M |
#2 | $4.1M | 28 | N/A | N/A |
#3 | $2M | 28 | 4% | $8.9M |
#4 | $3.5M | 28 | 47% | $30.1M |
#5 | $3.6M | 28 | -3% | N/A |